Canada’s drug review and reimbursement systems are onerous, duplicative, and inadequate. It can take between two to five years for some drugs to get to patients and even longer for precision medicines and medicines for rare diseases. Right now, only 60 per cent of treatments for rare disorders make it into Canada and most get approved up to six years later than in the USA and Europe.
This month, the Canadian Association of PNH Patients and other patient organizations across Canada are advocating for the millions of patients across Canada whose lives depend on medical breakthroughs.
Delayed access to life-changing medicines is impacting us all. The government must stop making changes to drug regulations that threaten our access.
Please support our efforts by sharing this post on your social channels and visiting www.protectouraccess.ca to send a message to your provincial and federal representatives.